1
Por Shih-Neng Yang, Wan-Chi Chiang, Kuei-Ting Chou, Geoffrey Zhang, Tzung-Chi Huang
Publicado em 2018-09-01
Obter o texto integralPublicado em 2018-09-01
Artigo
2
3
Por Chen, Kevin X., Venkatraman, Srikanth, Anilkumar, Gopinadhan N., Zeng, Qingbei, Lesburg, Charles A., Vibulbhan, Bancha, Velazquez, Francisco, Chan, Tin-Yau, Bennet, Frank, Jiang, Yueheng, Pinto, Patrick, Huang, Yuhua, Selyutin, Oleg, Agrawal, Sony, Huang, Hsueh-Cheng, Li, Cheng, Cheng, Kuo-Chi, Shih, Neng-Yang, Kozlowski, Joseph A., Rosenblum, Stuart B., Njoroge, F. George
Publicado em 2013
Obter o texto integralPublicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
4
Por Yu, Tao, Tagat, Jayaram R., Kerekes, Angela D., Doll, Ronald J., Zhang, Yonglian, Xiao, Yushi, Esposite, Sara, Belanger, David B., Curran, Patrick J., Mandal, Amit K., Siddiqui, M. Arshad, Shih, Neng-Yang, Basso, Andrea D., Liu, Ming, Gray, Kimberly, Tevar, Seema, Jones, Jennifer, Lee, Suining, Liang, Lianzhu, Ponery, Samad, Smith, Elizabeth B., Hruza, Alan, Voigt, Johannes, Ramanathan, Lata, Prosise, Winifred, Hu, Mengwei
Publicado em 2010
Obter o texto integralPublicado em 2010
Obter o texto integral
Obter o texto integral
Artigo
5
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor
Por Arasappan, Ashok, Bennett, Frank, Bogen, Stephane L., Venkatraman, Srikanth, Blackman, Melissa, Chen, Kevin X., Hendrata, Siska, Huang, Yuhua, Huelgas, Regina M., Nair, Latha, Padilla, Angela I., Pan, Weidong, Pike, Russell, Pinto, Patrick, Ruan, Sumei, Sannigrahi, Mousumi, Velazquez, Francisco, Vibulbhan, Bancha, Wu, Wanli, Yang, Weiying, Saksena, Anil K., Girijavallabhan, Viyyoor, Shih, Neng-Yang, Kong, Jianshe, Meng, Tao, Jin, Yan, Wong, Jesse, McNamara, Paul, Prongay, Andrew, Madison, Vincent, Piwinski, John J., Cheng, Kuo-Chi, Morrison, Richard, Malcolm, Bruce, Tong, Xiao, Ralston, Robert, Njoroge, F. George
Publicado em 2010
Obter o texto integralPublicado em 2010
Obter o texto integral
Obter o texto integral
Artigo